Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremie Vendome

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
ACS Medicinal Chemistry Letters|April 17, 2024
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable <i>In Vivo</i> Studies: Discovery of TDI-11055Mayako Michino, Tanweer A Khan, Michael W Miller, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Nature|November 29, 2019
Structure and drug resistance of the Plasmodium falciparum transporter PfCRTJonathan Kim, Yong Zi Tan, Kathryn J Wicht, et al.
Blood|October 28, 2016
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignanciesChangchun Deng, Mark R Lipstein, Luigi Scotto, et al.
ACS Infectious Diseases|February 22, 2018
Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosisAna Negri, Prisca Javidnia, Ran Mu, et al.
Journal of Medicinal Chemistry|January 19, 2022
In Vitro and In Vivo Inhibition of the <i>Mycobacterium tuberculosis</i> Phosphopantetheinyl Transferase PptT by AmidinoureasSamantha Ottavi, Sarah M Scarry, John Mosior, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Angewandte Chemie (International Ed. in English)|January 12, 2021
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized MiceWenhu Zhan, Hao Zhang, John Ginn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistanceLaura A Kirkman, Wenhu Zhan, Joseph Visone, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
ACS Medicinal Chemistry Letters|April 17, 2024
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable <i>In Vivo</i> Studies: Discovery of TDI-11055Mayako Michino, Tanweer A Khan, Michael W Miller, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Nature|November 29, 2019
Structure and drug resistance of the Plasmodium falciparum transporter PfCRTJonathan Kim, Yong Zi Tan, Kathryn J Wicht, et al.
Blood|October 28, 2016
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignanciesChangchun Deng, Mark R Lipstein, Luigi Scotto, et al.
ACS Infectious Diseases|February 22, 2018
Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosisAna Negri, Prisca Javidnia, Ran Mu, et al.
Journal of Medicinal Chemistry|January 19, 2022
In Vitro and In Vivo Inhibition of the <i>Mycobacterium tuberculosis</i> Phosphopantetheinyl Transferase PptT by AmidinoureasSamantha Ottavi, Sarah M Scarry, John Mosior, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Angewandte Chemie (International Ed. in English)|January 12, 2021
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized MiceWenhu Zhan, Hao Zhang, John Ginn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistanceLaura A Kirkman, Wenhu Zhan, Joseph Visone, et al.
Pageof 3